For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for NatWest Group plc (NWG) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-23): Designation Gem · Gem Score +36 (−100…+100 Quality+Value blend) · Quality 48 · Value 26 · Sentiment -20 (timing only, not weighted) · Composite fair value $27.36 vs $18.62 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
NatWest Group plc
NWG NYSENatWest Group plc Sponsored ADR represents American Depositary Receipts for shares of the NatWest Group plc, a major British banking and financial services organization. The primary function of these ADRs is to provide U.S. investors with easier access to invest in NatWest Group's shares without dealing with the complexities of international trading laws. The NatWest Group offers a wide array of financial products and services, encompassing retail and commercial banking across the UK and Ireland, corporate lending, and investment banking operations. A significant player in the financial sector, NatWest Group serves millions of customers, impacting industries from small and medium-sized enterprises to large multinational corporations. By offering these ADRs, NatWest Group taps into increased liquidity from U.S. markets and broadens its investor base. The NatWest Group ADRs on U.S. exchanges make it simpler for investors to participate in the performance of one of the UK’s leading banking conglomerates, without direct exposure to foreign exchanges or currency fluctuations.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
This company does not file structured financial statements with the U.S. SEC, so quarterly figures aren't available from our filings-based data engine. Annual figures shown here come from the sources that do cover it.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 1.84
Total Equity: $58.14B
Shares: 4,325,667,656
Total Debt: $0.00
Cash: $130.22B
EBITDA: N/A
Total Debt: $0.00
Cash: $130.22B
Revenue: $41.27B
Revenue: $41.27B
Revenue: $41.27B
Total Equity: $58.14B
Tax Rate: 24.3%
Equity: $58.14B
Total Debt: $0.00
Cash: $130.22B
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $58.14B
Shares: 4,325,667,656
Shares: 4,325,667,656
CapEx: -$907.38M
Shares: 4,325,667,656
Stock Price: $18.62
Net Income: $7.48B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 22, 2026 4:54pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $17.4B | $22.6B | $34.6B | $40.0B | $41.3B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $10.6B | $10.5B | $10.9B | $11.1B | $11.3B |
| Operating Income | — | — | — | — | — |
| Net Income | $4.0B | $4.6B | $6.0B | $6.2B | $7.5B |
| EBITDA | — | — | — | — | — |
| EPS | $0.75 | $0.92 | $1.31 | $1.46 | $1.86 |
| EPS (Diluted) | $0.74 | $0.92 | $1.30 | $1.45 | $1.84 |
Balance Sheet (Annual)
Last updated: Aug 22, 2026 4:54pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $260.2B | $216.2B | $162.1B | $143.1B | $130.2B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $1.1T | $982.5B | $945.1B | $966.0B | $975.0B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $1.0T | $932.7B | $894.4B | $912.3B | $916.8B |
| Total Equity | $57.0B | $49.8B | $50.7B | $53.7B | $58.1B |
| Retained Earnings | — | — | — | — | — |
Cash Flow (Annual)
Last updated: Aug 22, 2026 4:54pm (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $73.3B | -$59.5B | -$23.8B | $2.4B | $9.6B |
| Capital Expenditure | -$1.2B | -$871.9M | -$1.1B | -$633.1M | -$907.4M |
| Free Cash Flow | $72.0B | -$60.4B | -$24.9B | $1.8B | $8.7B |
| Acquisitions (net) | — | — | -$189.7M | — | — |
| Net Debt Issued / (Repaid) | — | — | — | — | — |
| Dividends Paid | -$1.4B | -$4.4B | -$2.3B | -$2.5B | -$3.2B |
| Stock Buybacks | — | — | — | — | — |
| Net Change in Cash | $70.3B | -$44.0B | -$54.1B | -$19.1B | -$12.8B |
Growth Trends (YoY %)
Last updated: Aug 22, 2026 4:54pm (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +29.6% | +53.1% | +15.5% | +3.1% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | +13.2% | +31.6% | +2.8% | +21.2% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 22, 2026 4:54pm (1d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-08-14 | $0.32 | — | — | — |
| 2026-03-20 | $0.62 | — | — | — |
| 2025-08-08 | $0.26 | — | — | — |
| 2025-03-14 | $0.39 | — | — | — |
| 2024-08-09 | $0.15 | — | — | — |
| 2024-03-14 | $0.29 | — | — | — |
| 2023-12-01 | $0.14 | — | — | — |
| 2023-08-10 | $0.14 | — | — | — |
| 2023-03-16 | $0.24 | — | — | — |
| 2022-08-30 | $0.45 | — | — | — |
| 2022-03-17 | $0.21 | — | — | — |
| 2021-08-12 | $0.09 | — | — | — |
| 2021-03-25 | $0.09 | — | — | — |
| 2020-03-26 | $0.24 | — | — | — |
| 2019-08-15 | $0.05 | — | — | — |
| 2019-03-21 | $0.10 | — | — | — |
| 2018-08-23 | $0.06 | — | — | — |
| 2008-05-29 | $13.75 | — | — | — |
| 2008-03-05 | $9.65 | — | — | — |
Deep Analysis
Narrative Economics
market-narrative step).
AI Lens 4th lens · how AI reaches this business · 5-yr
2026-08-11NatWest's dominant cost line is people and processing: mortgage underwriting, KYC/AML review, fraud triage, contact centres, complaint handling. Cheap intelligence compresses that headcount and per-transaction cost without requiring any change in what customers pay for credit or deposits.
AI-native front ends and aggregators can intermediate the customer relationship — comparison agents that reprice mortgages and sweep deposits to the best rate turn NatWest into a balance-sheet utility, eroding the deposit stickiness that funds cheap NII.
Whether AI-assisted rate shopping (agentic switching, open-banking sweeps) meaningfully raises deposit beta and mortgage churn. Observable: current-account balance retention, deposit cost pass-through vs base rate, and mortgage retention/refi spread disclosure.
UK banking licence, PRA/FCA capital and resolution regime, ~19m customer relationships with primary current-account status, and the payments/direct-debit plumbing embedded in household and SME operations.
AI Lens thesis
For NatWest, AI is a cost technology, not a revenue technology. The underlying need — deposits, credit, payments, regulated custody of money — is untouched by cheap intelligence, and the licence plus capital requirements mean an AI-native entrant cannot economically reproduce the balance sheet. So the direct effect runs through the expense line: a bank of this scale carries tens of thousands of staff in servicing, credit ops, financial crime and control functions where LLM-grade automation is genuinely substitutive, and regulators increasingly demand exactly the kind of exhaustive monitoring machines do cheaply. The offsetting mechanism is on the liability side: if agents make rate-shopping frictionless, the historically inert retail depositor becomes rate-sensitive, lifting funding costs and compressing NIM structurally — that is a bigger swing to earnings than any efficiency programme. Second-order, cheap intelligence also sharpens fraud and credit-model competence, which matters for a bank whose losses are model-driven, and arms fintech front-ends that already sit on top of NatWest rails. Net: modestly favourable, with the direction set by deposit behaviour rather than technology adoption.
What the market may be underestimating
Upside Financial-crime and regulatory-reporting cost — one of the fastest-growing bank expense lines — is precisely where AI substitutes for armies of reviewers; NatWest can convert a compliance tax into a durable per-account cost advantage over smaller UK lenders.
Downside Model-driven credit and fraud decisioning at scale creates concentrated conduct/redress risk: an AI-mediated mis-selling or biased-lending finding in the UK regime is remediated retrospectively across the whole book, as PPI and motor finance showed.
Outcome range spread 42
Growth Outlook
Analyzed 2026-08-22 17:16The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw numbers first: NatWest has quietly compounded revenue from $17.4B (2021) to $41.3B (2025) — a 24% CAGR that mostly reflects the rate cycle, not organic franchise growth. Net income roughly doubled from $4.03B to $7.48B over the same window, with 2025 NI up 21% YoY on just 3.1% revenue growth — that's operating leverage from a bank that has already earned its NIM expansion and is now squeezing costs. ROE of 12.9% is decent but not table-pounding; ROA of 0.77% is thin even by bank standards, meaning this is a leveraged spread business fully exposed to BoE rate cuts. At $18.62, 10.1x P/E, 1.39x P/B, and a 5.1% dividend at 43% payout, you're paid to wait but not paid extraordinarily.
The synthesis composite fair value of $27-28 (+51%) strikes me as too generous, and the thesis-evaluation score of -16 with bear mass 85.6 vs bull mass 69.2 is closer to the truth. The reason the DDM/book-value models spit out $27 is they capitalize current earnings at a "normalized" mid-teens ROE — but that ROE was manufactured by a once-in-a-decade rate spike. UK base rate is now cutting; every 25bp reduction on a UK bank's deposit franchise materially compresses NIM. The 21% earnings YoY vs 3.1% revenue YoY tells you 2025 is likely peak earnings, not trend earnings. Applying 10x to peak EPS is not "cheap" — it's fair-to-full. Book value support at 1.39x is real, but UK banks traded at 0.6-0.8x P/B for a decade post-GFC; there's no law requiring reversion to 2.0x.
A careful contrarian would note three things the models are underweighting. First, the balance sheet shows $130B cash and $58B equity but no total debt figure — for a bank this is nonsense; the "debt-to-equity: 0" is a data artifact hiding hundreds of billions of customer deposits and wholesale funding. Anyone taking that number at face value is mispricing risk. Second, the UK Treasury only fully exited its NWG stake in 2025 — the overhang that suppressed the multiple for a decade is finally gone, which is a genuine bull point the market-narrative model dismissed as "passive pessimism." Third, at 5.1% yield with 43% payout, there's room to grow the dividend even in a mild NIM compression scenario; the buyback cadence has been aggressive and shrinks the share count into any weakness. So the bear case isn't a slam dunk either.
Net: I dissent from the synthesis's $28 fair value but partially agree with its "fair_value" verdict header. My read is fair-to-slightly-undervalued in the $20-23 range, not $27+. The stock isn't a screaming buy — you're buying peak-cycle earnings at 10x with rate cuts as the primary reversal risk — but the combination of Treasury overhang removal, 5%+ yield, disciplined buybacks, and a genuine (if unexciting) UK oligopoly position argues against calling it overvalued at $18.62. The pre-flight framing of "mature_earner traditional bank" is correct; the narrative model correctly identifies this as anchored/fragile with no cult premium. Where I disagree most sharply is with the composite valuation's +51% upside — that's a rate-normalization fantasy. Own it for the yield and buyback, don't own it expecting a re-rating to 1.8x book.
GPT Reading
The numbers say NatWest is a plain, profitable bank that the market is still treating with more caution than the current earnings stream justifies. Revenue has climbed from $17.44B in 2021 to $41.27B in 2025, while net income rose from $4.03B to $7.48B over the same period. Even allowing for the fact that bank “revenue” is heavily rate-cycle influenced and not comparable to an industrial company’s sales, the direction matters: earnings power has not just recovered, it has materially reset higher. On the latest figures, the stock trades at 10.1x earnings, 1.39x book, and yields 5.1% with a 43% payout ratio. For a bank producing 12.9% ROE and nearly $8.74B of free cash flow, that is not demanding. The market cap is $74.0B against $58.1B of equity, so investors are paying about a $16B premium to book for a franchise generating roughly $7.5B of annual profit. That is a reasonable multiple of normalized earnings for a mature domestic bank, but not a full one.
What stands out most is that the valuation synthesis calling for roughly 50% upside is directionally right on cheapness but too aggressive on what multiple this business deserves. A 1.39x P/B for a 12.9% ROE bank is not distressed; it is a discount to a high-quality compounder, but NatWest is not that. This is a UK-focused lender whose recent revenue surge from $22.61B in 2022 to $34.63B in 2023 and then $40.01B in 2024 was almost certainly flattered by the rate environment. That makes the top-line CAGR of 9.2% less informative than it looks. Still, even if earnings have benefited from peak NIM conditions, the current price does not require heroic assumptions. At $18.62, investors are getting a business with an 18.1% net margin, double-digit ROE, and enough capital-generation capacity to fund both dividends and balance-sheet resilience. I do not buy the more bearish framing that 10x earnings means the market assumes stable mid-teens ROEs forever; if anything, 10x says the market already expects some giveback.
The balance sheet snapshot also argues against an outright bearish call. Cash and equivalents of $130.22B versus equity of $58.14B is not a full solvency analysis for a bank, but it does reinforce that this is not a fragile, over-levered story in the way bank bears often imply. Likewise, the “debt-to-equity 0” and negative EV/revenue are obvious classification artifacts, not signals; treating them literally would be a category error. More useful is the combination of 5.1% dividend yield, a sub-50% payout ratio, and 21.2% recent earnings growth. Even if that earnings growth normalizes sharply lower, the stock does not look priced for much expansion. My read is that fair value is above the current price, but closer to the low-to-mid $20s than the high $20s. A bank earning around 13% on equity should trade nearer 1.5x-1.7x book if those returns are durable; applying even 1.55x to $58.14B of equity implies about $90B of market value, or roughly 20%-25% upside from here, before dividends.
The best case against this view is straightforward: nearly all of the optical cheapness could disappear if 2025 marks peak earnings. Net income was $6.00B in 2023, $6.17B in 2024, then $7.48B in 2025; that last jump may not be repeatable in a lower-rate environment. If ROE slides from 12.9% back toward 9%-10%, then 1.39x book is not especially cheap at all, and 10x earnings could quickly become 12x-13x on a reduced earnings base. The market narrative about UK domestic banking being structurally ex-growth also has real substance: slower loan growth, tougher deposit competition, and greater sensitivity to the Bank of England cycle mean the 2021-2025 revenue trajectory likely overstates underlying franchise growth. I weigh these risks seriously, which is why I would not call the shares dramatically mispriced. But the bear case needs a material erosion in earnings, not just mild normalization, to justify today’s valuation.
What would change my mind is simple. If the next annual cycle shows revenue stalling or falling and net income dropping back below roughly $6.0B, with ROE slipping under 11%, then the current discount is probably deserved and I would move to fairly valued at best. Conversely, if NatWest can hold earnings above $7B while sustaining a payout ratio around 40%-45% and book value continues to compound, then the market should pay more than 1.39x book and the shares should migrate into the $22-$24 range without needing any heroic rerating.
Grok Reading
NatWest’s five-year income progression is the clearest story in the data: revenue climbed from $17.44B in 2021 to $41.27B in 2025, with net income rising from $4.03B to $7.48B. That is not a slow grind; it is a rate-cycle windfall layered on a large UK deposit franchise. The latest step still shows earnings power—net income up 21.2% year-on-year to $7.48B even as revenue growth slowed to 3.1%—and the 18.1% net margin plus 12.9% ROE put the bank in respectable mid-cycle territory for a domestic lender. At $18.62 the stock screens at 10.1x earnings and 1.39x book on $58.14B of equity, while throwing off a 5.1% dividend covered by a 43% payout and $8.74B of free cash flow against only $907M of capex. Operating cash flow of $9.65B and a cash pile of $130B reinforce the “fortress” balance-sheet claim; the zero debt-to-equity print is consistent with a deposit-funded model rather than wholesale leverage. For a bank still earning low-to-mid teens ROE, a double-digit free-cash-flow yield and a mid-single-digit dividend, $18.62 looks like a discount to the cash the franchise is currently generating, not a fair reflection of it.
The deceleration in top-line growth is real and matters. Revenue CAGR of 9.2% over the expansion phase is already fading, and the bulk of the 2022–2024 revenue surge was NIM expansion that will not repeat if the Bank of England keeps cutting. ROA at 0.77% underscores how much of the earnings engine depends on scale and spread rather than fee intensity. The valuation composite pointing near $27–$28 implies more than 50% upside, yet that figure sits awkwardly beside mixed method signals and a thesis score that already leans slightly negative on NIM reversal and UK credit risk. I do not need $28 to call the stock cheap; even a more conservative anchor in the low-to-mid $20s would still leave meaningful upside from here if earnings stabilize anywhere near the $6.5–7.5B range the last two years have delivered.
The strongest counter-case is straightforward: the market is correctly discounting a mean-reversion in net interest income and a softer UK macro path. If rates fall further and loan demand stagnates, the 21% earnings jump just posted becomes the high-water mark rather than a new base, and a 10x multiple on peak-ish earnings is not a bargain. Single-country concentration, thin fee diversification, and structural deposit competition from fintechs all argue that mid-teens ROE is not a permanent entitlement. A UK recession that lifts credit losses would hit both the income statement and the 1.39x book multiple at once. That is the rational skepticism embedded in the price, and it is grounded in observable cycle risk rather than narrative panic.
I would flip toward fair value or overvalued if the next two reporting periods show NIM compression of more than ~20–30 bps without offsetting volume or fee gains, if UK unemployment and arrears data deteriorate enough to push credit costs decisively higher, or if management is forced to cut the dividend or raise capital. Conversely, stable or only mildly lower NIMs with flat-to-up net income and continued capital returns would confirm that $18.62 was too pessimistic on through-cycle earnings power.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
NatWest looks like a mature, profitable universal bank in genuine improvement mode. Revenue has climbed from 17.4B in 2021 to 41.3B in 2025, net income from 4.0B to 7.5B, and diluted share count has been cut from 6.00B to 4.33B — a roughly 7.8% annual reduction that meaningfully concentrates per-share economics. Reported FCF of 8.7B in 2025 covers buybacks and dividends, and the 130B liquid asset figure reflects a deposit-funded bank balance sheet rather than a true corporate cash hoard.
Verify before trusting this (6)
- CET1 ratio, liquidity coverage, and leverage ratio versus PRA requirements
- Cost/income ratio trend and 2025 NIM guidance
- Stage 3 loans, coverage ratios, and UK mortgage/commercial real-estate exposure
- Composition of the 130B 'liquid cash' — how much is HQLA vs central bank reserves vs customer-funded
- Buyback authorization remaining and any residual UK government stake dynamics
- Reconciliation of OCF vs net income — is the gap trading-book/derivative noise or genuine accrual build
The e2e composite fair value of $27.36 (signal-adjusted $28.13) implies roughly 47-51% upside from $18.62. That anchors on a PE-based method, which is the right frame for a bank throwing off normalized earnings and buying back stock aggressively. I don't think the FV is a runaway - UK banks routinely trade 7-9x earnings versus 10-12x for global peers, and closing even half that gap gets you to the mid-$20s. So the direction is credible, but the magnitude assumes the UK bank discount narrows, which has been a decade-long widowmaker trade. Applying the earnings-quality haircut (poor, -2) and the structural UK-bank discount, I'd shade deserved value down to roughly $22-24 rather than $27. Against $18.62 that's a 15-25% gap - modest margin of safety, not a fat pitch. The Solid quality grade supports paying closer to deserved value, but doesn't turn a mid-teens discount into a screaming buy. Buybacks at these levels are accretive and provide a floor, which is the real reason to like the setup here.
Verify before trusting this (4)
- Forward NIM guidance and deposit beta trends in next results
- CET1 ratio and pace of buyback authorization
- UK mortgage book credit quality and stage 2/3 migration
- Any government stake overhang from remaining Treasury shares
The macro tape is nominally risk-on (score +32, VIX 15) but nascent and only 1 day old, so it offers limited lift. With beta 0.82, NWG is a low-sensitivity name that neither catches full upside in a risk chase nor gets mauled in a wobble — the tape barely moves the needle here. UK banks as a cohort still carry a 'fallen-angel, slow-bleed cash cow' overlay, and the narrative read is explicitly minimal-intensity and fragile: there is no active story running the stock, bull or bear. That vacuum means sentiment is not a decisive force in either direction. Macro rates (10y 4.69%, curve barely positive) are a mild ambient headwind for UK banks via NIM compression fears and deposit competition, and the market PE 25.7 signals investors are paying for growth stories elsewhere, not for capital-return UK financials. Recent momentum is neutral, with the 3-month trailing the long-term trend — a subtle sign of drift, not conviction. Unexplained 5% up-days and 3% down-days on no news suggest the tape, not a narrative, is driving prints. Net: no cult, no crisis, mild macro drag on the sector, offset by a benign broad tape. Balanced, leaning very slightly heavy.
Verify before trusting this (4)
- Whether UK bank sector flows turn on any BoE rate-path shift or a peer's NIM guide
- Any dividend or buyback announcement that could ignite a capital-return narrative
- Signs the fragile narrative flips - a fintech deposit-flight headline or, conversely, a re-rating catalyst across UK banks
- VIX behavior and whether the nascent risk-on regime holds beyond a few sessions
For NatWest, AI is a cost technology, not a revenue technology. The underlying need — deposits, credit, payments, regulated custody of money — is untouched by cheap intelligence, and the licence plus capital requirements mean an AI-native entrant cannot economically reproduce the balance sheet. So the direct effect runs through the expense line: a bank of this scale carries tens of thousands of staff in servicing, credit ops, financial crime and control functions where LLM-grade automation is genuinely substitutive, and regulators increasingly demand exactly the kind of exhaustive monitoring machines do cheaply. The offsetting mechanism is on the liability side: if agents make rate-shopping frictionless, the historically inert retail depositor becomes rate-sensitive, lifting funding costs and compressing NIM structurally — that is a bigger swing to earnings than any efficiency programme. Second-order, cheap intelligence also sharpens fraud and credit-model competence, which matters for a bank whose losses are model-driven, and arms fintech front-ends that already sit on top of NatWest rails. Net: modestly favourable, with the direction set by deposit behaviour rather than technology adoption.
None surfaced.
Verify before trusting this (8)
- UK mortgage and SME lending volumes
- Primary current-account customer counts
- Deposit balances vs system growth
- NIM disclosure quarter to quarter
- Deposit mix shift to term products
- Fee income share of revenue
- Aggregator-originated mortgage share
- API call volume from third parties
The world is currently paying UK domestic banks for the back half of the rate cycle: elevated but easing policy rates, a steepening-ish curve (0.5), and a structural hedge that converts yesterday's low-rate swaps into tomorrow's income. That is a 2-3 year mechanical tailwind, not a permanent one. Against it sits a low-growth UK economy, fiscal pressure that repeatedly targets bank profits, and fintech/neobank competition for the cheapest deposits — which raises the cost of the very funding advantage that makes this model work. The bear's 'secular decline' framing overstates near-term reality: deposit franchises with current-account primacy are still highly defensible and credit is benign. The bull's 'fortress' framing is fair on balance sheet but must not be read as a growth engine — this is a mid-single-digit income business converting into higher-single/low-double-digit per-share earnings growth via cost control and buybacks.
When we made this prediction on Aug 23, 2026, NWG was $18.62. We expect it to be $22.40 by Feb 2027, and we consider it great value under $16.50. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 23, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.